TNF and cancer: The subsequent cancer rate per 100 p-y for VDZ was 1.9 (6 patients amongst 37 exposed to VDZ), and it was not statistically different from patients exposed to USK, anti-TNFα, IMM, or no therapy (3.0, 3.8, 1.6, and 2.7, respectively, p = 0.41).